Innovative Drug Discovery Company, Domainex, Collaborates With Breakthrough Breast Cancer And Institute Of Cancer Research On Novel Drug Targets

News — By on March 18, 2009 at 6:00 am

Domainex announced a collaboration on new exciting drug discovery programmes with the Breakthrough Breast Cancer Research Centre and The Institute of Cancer Research to identify and develop inhibitors of two recently validated breast cancer targets, tankyrase and IKK-epsilon.

Please read the complete article and let us know what you think below.

Leave a Reply

Trackbacks

Leave a Trackback